News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
148 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (21720)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
2 (186)
3 (175)
4 (147)
5 (166)
6 (119)
9 (121)
10 (183)
11 (172)
12 (142)
13 (112)
14 (38)
15 (1)
16 (171)
17 (154)
18 (148)
19 (149)
20 (92)
21 (2)
23 (153)
24 (148)
25 (216)
26 (204)
27 (119)
28 (2)
29 (9)
30 (193)
31 (218)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
9
10
11
12
13
14
15
16
17
18
19
20
21
23
24
25
26
27
28
29
30
31
Biotech Bay
NeuroPace Bags $74M to Market Epilepsy Device
NeuroPace snagged $74M in funding to expand commercialization of its device that treats epileptic seizures.
October 24, 2017
·
2 min read
·
Alex Keown
Drug Development
Gilead Shows Off Mid-Stage NASH Data
Gilead released results from a Phase II clinical trial of GS-0976 for NASH.
October 24, 2017
·
2 min read
·
Mark Terry
Business
Biogen Throws Another $200M at Aducanumab With Amended Deal With Neurimmune
Despite the failures of late stage ALZ’s drugs developed by numerous companies, Biogen seems confident in the future of its amyloid plaque targeting aducanumab.
October 24, 2017
·
2 min read
·
Alex Keown
Business
AbbVie Plows $205M Upfront Into Alector’s Alzheimer’s Program
AbbVie announced a strategic collaboration with Alector to develop and commercialize drugs for ALZ’s disease and other neurodegenerative disorders.
October 24, 2017
·
3 min read
·
Mark Terry
BioMidwest
3 High Potential Low Risk Biotechs Investors Should Watch Out For
When you think about it, most small biotech companies are odd investments.
October 24, 2017
·
3 min read
·
Mark Terry
Deals
Massachusetts Upstart scPharmaceuticals Files for $100M IPO
scPharmaceuticals filed recently with the SEC regarding its plans for an IPO.
October 24, 2017
·
2 min read
·
Mark Terry
Business
Vyaire Inks Huge Lease in Irvine to Expand
Vyaire Medical, a Chicago-based firm formerly known as CareFusion, is shifting its Orange County base to Irvine from Yorba Linda.
October 24, 2017
·
1 min read
Medicrea Launches UNiD HUB Proprietary Surgical Planning Through Machine Learning at NASS 2017
MEDICREA announced today that the Company will launch their UNiD HUB software at the 32nd Annual Meeting of the North American Spine Society (NASS), held October 25-28, 2017 in Orlando, Florida.
October 24, 2017
·
3 min read
Sequana Medical Announces Results of the MOSAIC Trial Data Presented at 2017 AASLD
Sequana Medical today announced that Prof. Florence Wong, University of Toronto, presented the findings of the MOSAIC study data at the Annual Meeting of the AASLD Annual Meeting , held in Washington, DC.
October 24, 2017
·
4 min read
Deals
Bracket Acquires mProve Health to Radically Advance Patient Engagement in Clinical Trials
Bracket today announced the strategic acquisition of mProve, a leading provider of mobile technologies for life science companies.
October 24, 2017
·
4 min read
1 of 15
Next